The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) aims to be recognized globally as a “home of responsible innovation” when it comes to regulating software and artificial intelligence (AI) when used as medical devices.
This is according to its new software and AI as a medical device change program, the details of which were published on 17 October, in a roadmap that outlines 11 “work packages” it will undertake when developing its regulatory framework
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?